Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology. - Test2 - elhamkhani - TriplyDB

Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

http://www.wikidata.org/entity/Q36184758

about

Nano-Synthetic Devices in Leishmaniasis: A Bioinformatics Approach.Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA Biodistribution and Toxicity Studies of PRINT Hydrogel Nanoparticles in Mosquito Larvae and Cells Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor Generation of siRNA Nanosheets for Efficient RNA Interference RNAi-microsponges form through self-assembly of the organic and inorganic products of transcription.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.Transfected early growth response gene-1 DNA enzyme prevents stenosis and occlusion of autogenous vein graft in vivo Innovative delivery of siRNA to solid tumors by super carbonate apatite.Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells.Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.New approach to develop ultra-high inhibitory drug using the power function of the stoichiometry of the targeted nanomachine or biocomplex.A Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs Computational selection and experimental validation of allosteric ribozymes that sense a specific sequence of human telomerase reverse transcriptase mRNAs as universal anticancer therapy agents Aptamer-based therapeutics: new approaches to combat human viral diseases Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.Stable RNA nanoparticles as potential new generation drugs for cancer therapy.Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.Ultrastable pRNA hexameric ring gearing hexameric phi29 DNA-packaging motor by revolving without rotating and coiling.Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.Discovery of a new method for potent drug development using power function of stoichiometry of homomeric biocomplexes or biological nanomotors Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.Controllable self-assembly of RNA dendrimers RNA as a boiling-resistant anionic polymer material to build robust structures with defined shape and stoichiometry.Entropy-driven one-step formation of Phi29 pRNA 3WJ from three RNA fragments.Advancement of the Emerging Field of RNA Nanotechnology.Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.Bubbled RNA-Based Cargo for Boosting RNA Interference.Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties.RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity.Picomolar Fingerprinting of Nucleic Acid Nanoparticles Using Solid-State Nanopores.Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.RNA nanoparticle distribution and clearance in the eye after subconjunctival injection with and without thermosensitive hydrogels.Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.

P2860

Q26852294-A5C1741F-851B-44C1-9860-542A91791EBE Q27679196-FA0386E7-4250-4E4B-8421-673F19594DCC Q28547397-89C47554-B431-4B5E-8C5A-F652F76A07D0 Q28817578-A51DEE63-36A5-4518-80E0-F89FCBE1B824 Q28834048-CBE99697-6F61-4ABF-8D91-8994DCC28424 Q33652451-E83F5B0A-E414-484F-B3D8-520744978192 Q33859472-7B9AC502-AD14-46BB-BBB7-9522CDFE1B4D Q34011377-C0A43F74-969D-4E39-A5E6-D61752B6EECC Q34668067-BB7CFED7-823A-439F-808E-2AAECFCD7EEF Q35571504-B9FE9A53-E20C-46E4-80FA-646CD796BFA9 Q35813076-71F014AF-53CC-4CE3-82B3-6B7F3301EDB9 Q35866025-C518A303-BAD0-4F73-B124-A746E6E402A9 Q36020835-03B53C60-E9ED-4E93-8F8D-519159CC929E Q36426580-438E4C69-7CEE-4B95-A0BD-6F9E05DC3A9D Q36490744-64DE1010-AA49-409F-88AF-5548A11748AA Q36522581-99F1626A-12B4-4B7B-8CB6-54399BD6AD65 Q36622859-C32567F3-7210-49C5-B4CE-FFBC415D80D6 Q37404058-91CE6FC4-5766-46BA-98E6-70627EED4A6F Q37415958-C3566EE8-3D23-4052-A912-83E4998D6F58 Q37442480-220CE09C-4822-4FA8-BBFE-575FD4EA5DEA Q37640468-DF887757-403D-4D30-BA30-2159733A7092 Q38106032-5A8CD3DE-3282-421A-8E60-0FE3746D5FB4 Q38107616-6CAE17A4-245F-4EF8-AA92-4355D10449AA Q38127412-BB1DD98C-2139-4CE7-B453-8638D89506E1 Q38573837-B3232DCE-1261-41D2-94BC-B21C4B2D5FB0 Q38774730-D8FE963E-2F64-4E18-8AB7-545DE6D122DA Q38812570-19191C09-C2C8-4E53-AC63-9B6677F0A175 Q39008942-9D4259AF-96C7-4A59-B7EC-DABD82AA3A83 Q39044626-1C37E156-E53A-4E30-A263-FA67E967CFCA Q39065708-058FAA80-52E5-47D5-9616-6514828E0790 Q39162819-57BF9808-8DD2-49F8-9D8F-369FBBFBF902 Q40564594-8E4B4D30-E04A-4FE8-82D7-11F907A79020 Q41482524-AADA9593-9B49-4CD7-B9A5-068A8767B445 Q41885592-3776A636-D07B-48B5-AA87-BA4861317412 Q45863841-197261E9-8B83-4F58-A94E-EBE4BB2ADC87 Q47117123-7F1AEDFB-E025-417C-AFA1-43933F12F727 Q48174925-70622103-0775-4A2A-A0ED-603ED729A1A9 Q49529515-F0875D1D-2257-4E7A-8B02-72FFA44AD4FC Q49693374-76FF56D0-9B11-4B9F-B01D-2653EBB11D47 Q52589516-DFED3708-A77F-490D-AF94-5AAE064CF179

P2860

Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

http://www.wikidata.org/entity/Q36184758

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Uniqueness, advantages, challe ...... s applying RNA nanotechnology.

@ast

Uniqueness, advantages, challe ...... s applying RNA nanotechnology.

@en

type

label

Uniqueness, advantages, challe ...... s applying RNA nanotechnology.

@ast

Uniqueness, advantages, challe ...... s applying RNA nanotechnology.

@en

prefLabel

Uniqueness, advantages, challe ...... s applying RNA nanotechnology.

@ast

Uniqueness, advantages, challe ...... s applying RNA nanotechnology.

@en

P1433

Q36184758-97722696-2201-4F12-895A-D8E9A1BCEF66

P1476

Q36184758-C2118040-D5EB-439E-9ADC-359BDC09976B

P2093

Q36184758-4F477234-47C2-4D7A-A32C-7EA58BB1348E

Q36184758-99CD7919-BA87-47CB-86AF-3B9E88192752

Q36184758-D2CD8DFC-710D-4C68-B31B-A08CB3A46D7B

Q36184758-DBAFC727-C9AA-44D4-A445-F97C187ACC96

Q36184758-F669D9C4-B407-4BC5-B242-4C9F2B416471

P2860

Q36184758-00CB189A-E8DF-4E64-B9DC-040B197429FC

Q36184758-01A4F6E6-5C32-4E6C-94C6-B6228E70E574

Q36184758-0257E66C-BFC8-49A0-91C5-36E12CE8FF6F

Q36184758-02F23E73-6F3F-4166-AC56-7CCA01397BB6

Q36184758-06A171DC-670A-4B01-8D3A-D4CF51D2A7EB

Q36184758-0801774F-DD5F-4757-84A6-4D22A092B673

Q36184758-08C9087F-07CB-4A3C-8760-DCEA96EB1563

Q36184758-08E04316-DE82-458F-831E-4941BB1D46B2

Q36184758-08E1CC4B-AD07-4895-8AE7-AEC88FC8F53D

Q36184758-08E644F5-D127-4EDE-A6E5-213D125DAFE9

P304

Q36184758-63399F65-3DF9-420F-94CE-C2015D460847

P31

Q36184758-26C47372-126D-4F60-995F-29BB8B0C5734

P356

Q36184758-FA6F0413-E59A-48D7-9F39-C6175A10DE87

P433

Q36184758-93182A73-85DB-41E8-95DC-60D0C22E9A5A

P478

Q36184758-64519670-0CF9-41CA-A464-122C8010B539

P577

Q36184758-6D66232A-44A9-4758-B9E9-051CCA9DF5D8

P5875

Q36184758-A2FE47FF-EED2-4947-8831-585080797655

P698

Q36184758-64B5D314-B449-48B5-8CCC-D676DEE3F546

P921

Q36184758-BEF66379-0003-4DEA-A862-46F941726DB7

P932

Q36184758-BBF827C8-EC22-4705-9DE8-E786B5925DF1

P356

P1433

Nucleic Acid Therapeutics

P1476

Uniqueness, advantages, challe ...... s applying RNA nanotechnology.

@en

P2093

Brent Hallahan

http://www.w3.org/2001/XMLSchema#string

Farzin Haque

http://www.w3.org/2001/XMLSchema#string

Hui Li

http://www.w3.org/2001/XMLSchema#string

Peixuan Guo

http://www.w3.org/2001/XMLSchema#string

Randall Reif

http://www.w3.org/2001/XMLSchema#string

P2860

The distributions, mechanisms, and structures of metabolite-binding riboswitches

De novo synthesis and development of an RNA enzyme

Nanomaterials based on DNA

MicroRNAs: target recognition and regulatory functions

The emerging field of RNA nanotechnology

A new principle of RNA folding based on pseudoknotting

Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure

MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders

Controlling RNA self-assembly to form filaments.

Current advances in Phi29 pRNA biology and its application in drug delivery

P304

226-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/NAT.2012.0350

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230721525

http://www.w3.org/2001/XMLSchema#string

P698

22913595

http://www.w3.org/2001/XMLSchema#string

P921

P932

3426230

http://www.w3.org/2001/XMLSchema#string